MMP1 and breast carcinoma: These findings suggest that miR-202-3p loss plays a critical role in brain metastasis of breast cancer by upregulating MMP-1 and that the miR-202-3p/MMP-1 axis may represent a potential prognostic and therapeutic target to predict and prevent breast cancer brain metastasis.